Dolby Laboratories (NYSE:DLB) Issues Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) updated its first quarter 2025 earnings guidance on Tuesday. The company provided EPS guidance of 0.960-1.110 for the period, compared to the consensus EPS estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Stock Down 0.6 %

Shares of NYSE DLB traded down $0.42 during midday trading on Tuesday, hitting $70.93. 416,799 shares of the company’s stock were exchanged, compared to its average volume of 396,175. The firm has a market capitalization of $6.76 billion, a PE ratio of 32.38 and a beta of 0.98. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06. The company’s 50 day moving average price is $73.66 and its 200 day moving average price is $76.09.

Dolby Laboratories announced that its Board of Directors has approved a stock repurchase program on Wednesday, August 7th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to reacquire up to 5% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

DLB has been the subject of several research reports. StockNews.com upgraded shares of Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday. Barrington Research restated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 20th.

Read Our Latest Analysis on Dolby Laboratories

Insiders Place Their Bets

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total value of $2,113,309.44. Following the transaction, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. This represents a 25.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 39.54% of the company’s stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.